Literature DB >> 25059240

Acute volume loading and exercise capacity in postural tachycardia syndrome.

Rocío A Figueroa1, Amy C Arnold1, Victor C Nwazue1, Luis E Okamoto1, Sachin Y Paranjape1, Bonnie K Black1, Andre Diedrich1, David Robertson2, Italo Biaggioni2, Satish R Raj2, Alfredo Gamboa3.   

Abstract

Postural tachycardia syndrome (POTS) is associated with exercise intolerance, hypovolemia, and cardiac atrophy, which may contribute to reduced stroke volume and compensatory exaggerated heart rate (HR) increases. Acute volume loading with intravenous (iv) saline reduces HR and improves orthostatic tolerance and symptoms in POTS, but its effect on exercise capacity is unknown. In this study, we determined the effect of iv saline infusion on peak exercise capacity (VO2peak) in POTS. Nineteen patients with POTS participated in a sequential study. VO2peak was measured on two separate study days, following administration of placebo or 1 liter of i.v. saline (NaCl 0.9%). Patients exercised on a semirecumbent bicycle with resistance increased by 25 W every 2 min until maximal effort was achieved. Patients exhibited blood volume deficits (-13.4 ± 1.4% ideal volume), consistent with mild to moderate hypovolemia. At baseline, saline significantly increased stroke volume (saline 80 ± 8 ml vs. placebo 64 ± 4 ml; P = 0.010), increased cardiac output (saline 6.9 ± 0.5 liter/min vs. placebo 5.7 ± 0.2 liter/min; P = 0.021), and reduced systemic vascular resistance (saline 992.6 ± 70.0 dyn-s/cm(5) vs. placebo 1,184.0 ± 50.8 dyn-s/cm(5); P = 0.011), with no effect on HR or blood pressure. During exercise, saline did not produce differences in VO2peak (saline 26.3 ± 1.2 mg·kg(-1)·min(-1) vs. placebo 27.7 ± 1.8 mg·kg(-1)·min(-1); P = 0.615), peak HR [saline 174 ± 4 beats per minute (bpm) vs. placebo 175 ± 3 bpm; P = 0.672] or other cardiovascular parameters. These findings suggest that acute volume loading with saline does not improve VO2peak or cardiovascular responses to exercise in POTS, despite improvements in resting hemodynamic function.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  POTS; autonomic diseases; deconditioning

Mesh:

Substances:

Year:  2014        PMID: 25059240      PMCID: PMC4157162          DOI: 10.1152/japplphysiol.00367.2014

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  35 in total

1.  Effect of acute plasma volume expansion on thermoregulation and exercise performance in the heat.

Authors:  M J Watt; A P Garnham; M A Febbraio; M Hargreaves
Journal:  Med Sci Sports Exerc       Date:  2000-05       Impact factor: 5.411

2.  ATS/ACCP statement on cardiopulmonary exercise testing.

Authors:  Robert M Ross
Journal:  Am J Respir Crit Care Med       Date:  2003-05-15       Impact factor: 21.405

3.  What is brain fog? An evaluation of the symptom in postural tachycardia syndrome.

Authors:  Amanda J Ross; Marvin S Medow; Peter C Rowe; Julian M Stewart
Journal:  Clin Auton Res       Date:  2013-09-03       Impact factor: 4.435

4.  Power and sample size calculations. A review and computer program.

Authors:  W D Dupont; W D Plummer
Journal:  Control Clin Trials       Date:  1990-04

5.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

6.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

7.  Postural tachycardia syndrome: clinical features and follow-up study.

Authors:  P Sandroni; T L Opfer-Gehrking; B R McPhee; P A Low
Journal:  Mayo Clin Proc       Date:  1999-11       Impact factor: 7.616

8.  Effects of rapid saline infusion on orthostatic intolerance and autonomic tone after 20 days bed rest.

Authors:  Katsu Takenaka; Yoji Suzuki; Kansei Uno; Michiko Sato; Takako Komuro; Yuichiro Haruna; Hideyuki Kobayashi; Kiyoshi Kawakubo; Makoto Sonoda; Masako Asakawa; Kazuhiko Nakahara; Atsuaki Gunji
Journal:  Am J Cardiol       Date:  2002-03-01       Impact factor: 2.778

9.  Plasma volume expansion does not increase maximal cardiac output or VO2 max in lowlanders acclimatized to altitude.

Authors:  José A L Calbet; Göran Rådegran; Robert Boushel; Hans Søndergaard; Bengt Saltin; Peter D Wagner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-13       Impact factor: 4.733

10.  Exercise response after rapid intravenous infusion of saline in healthy humans.

Authors:  H Thomas Robertson; Riccardo Pellegrino; Daniela Pini; Jacopo Oreglia; Stefano DeVita; Vito Brusasco; PierGiuseppe Agostoni
Journal:  J Appl Physiol (1985)       Date:  2004-04-16
View more
  6 in total

1.  Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult.

Authors:  Jeffrey P Moak; Derek Leong; Robin Fabian; Vicki Freedenberg; Elizabeth Jarosz; Carol Toney; Sridhar Hanumanthaiah; Anil Darbari
Journal:  Pediatr Cardiol       Date:  2015-10-07       Impact factor: 1.655

2.  Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing.

Authors:  William M Oldham; Gregory D Lewis; Alexander R Opotowsky; Aaron B Waxman; David M Systrom
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  Effects of intermittent intravenous saline infusions in patients with medication-refractory postural tachycardia syndrome.

Authors:  Mohammed Ruzieh; Aaron Baugh; Osama Dasa; Rachel L Parker; Joseph T Perrault; Anas Renno; Beverly L Karabin; Blair Grubb
Journal:  J Interv Card Electrophysiol       Date:  2017-02-09       Impact factor: 1.900

Review 4.  Exercise in the postural orthostatic tachycardia syndrome.

Authors:  Qi Fu; Benjamin D Levine
Journal:  Auton Neurosci       Date:  2014-11-21       Impact factor: 3.145

5.  Postural orthostatic tachycardia syndrome as a sequela of COVID-19.

Authors:  Cameron K Ormiston; Iwona Świątkiewicz; Pam R Taub
Journal:  Heart Rhythm       Date:  2022-07-16       Impact factor: 6.779

Review 6.  Dyspnea in Chronic Low Ventricular Preload States.

Authors:  Rubabin Tooba; Kenneth A Mayuga; Robert Wilson; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2021-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.